Mid career · publishing since 2007Rising activity
Sarcoma Diagnosis and TreatmentRNA modifications and cancerNeurofibromatosis and Schwannoma CasesChromatin Remodeling and CancerVirus-based gene therapy research
Publications
147
Citations
802
Est. group size
~2
Recurring co-author estimate
Active years
20
Publishing since 2007
In context
Among 4,491 mid career Medicine PIs within our index
Citations: 802p25 240 · p75 1,552 · cohort median 614
Publications / year (recent): 22.2p25 1.8 · p75 7.2 · cohort median 3.4
Typically publishes in teams of ~19 · 0% small-team papers (≤3 authors) · across 5 venues
Publication cadence
Publications per year over the last 10 years — averaging 22.2/year recently
Recent publications
- Data from Genomic Status of <i>MET</i> Potentiates Sensitivity to MET and MEK Inhibition in NF1-Related Malignant Peripheral Nerve Sheath Tumors
2023
- Table S2 from Genomic Status of <i>MET</i> Potentiates Sensitivity to MET and MEK Inhibition in NF1-Related Malignant Peripheral Nerve Sheath Tumors
2023
- Figure S4 from Genomic Status of <i>MET</i> Potentiates Sensitivity to MET and MEK Inhibition in NF1-Related Malignant Peripheral Nerve Sheath Tumors
2023
- Figure S6 from Genomic Status of <i>MET</i> Potentiates Sensitivity to MET and MEK Inhibition in NF1-Related Malignant Peripheral Nerve Sheath Tumors
2023
- Figure S2 from Genomic Status of <i>MET</i> Potentiates Sensitivity to MET and MEK Inhibition in NF1-Related Malignant Peripheral Nerve Sheath Tumors
2023
- Table S1 from Genomic Status of <i>MET</i> Potentiates Sensitivity to MET and MEK Inhibition in NF1-Related Malignant Peripheral Nerve Sheath Tumors
2023
- Figure S1 from Genomic Status of <i>MET</i> Potentiates Sensitivity to MET and MEK Inhibition in NF1-Related Malignant Peripheral Nerve Sheath Tumors
2023
- Figure S5 from Genomic Status of <i>MET</i> Potentiates Sensitivity to MET and MEK Inhibition in NF1-Related Malignant Peripheral Nerve Sheath Tumors
2023
- Figure S3 from Genomic Status of <i>MET</i> Potentiates Sensitivity to MET and MEK Inhibition in NF1-Related Malignant Peripheral Nerve Sheath Tumors
2023
- Supplementary Table S1 from Mitogen-activated protein kinase kinase signaling promotes growth and vascularization of fibrosarcoma
2023
- Supplementary Fig. S2 from Mitogen-activated protein kinase kinase signaling promotes growth and vascularization of fibrosarcoma
2023
- Supplementary Figure Legends from Mitogen-activated protein kinase kinase signaling promotes growth and vascularization of fibrosarcoma
2023
- Supplementary Fig. S1 from Mitogen-activated protein kinase kinase signaling promotes growth and vascularization of fibrosarcoma
2023
- Supplementary Figure Legends from Mitogen-activated protein kinase kinase signaling promotes growth and vascularization of fibrosarcoma
2023
- Supplementary Fig. S2 from Mitogen-activated protein kinase kinase signaling promotes growth and vascularization of fibrosarcoma
2023
Publishes in
- Cancer Research×14
- Clinical Cancer Research×2
- Molecular Cancer Therapeutics×2
- bioRxiv (Cold Spring Harbor Laboratory)×2
- Tumor Biology×2
Similar researchers
By research-topic overlap
- Julia Selich‐Anderson
Medicine · The Ohio State University
- Patrick J. Grohar
Medicine · University of Michigan
- Stephen L. Lessnick
Medicine · The Ohio State University
- Christopher D. Collier
Medicine · Indiana University
- Lucia Casadei
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile